Regular exercise, clean eating, and a glowing doctor’s report might feel reassuring—but they don’t guarantee protection from heart disease.
Standard annual checkups often miss critical warning signs until it’s too late, and they frequently overlook the markers that matter most.
Someone can have normal cholesterol, feel fantastic, and receive a clean bill of health while dangerous plaque silently accumulates in their arteries.
In a recent video, Dr. Lean Kim, a double board-certified physician specializing in longevity and metabolic health, revealed the hidden risk factors behind heart attacks in seemingly healthy people—and the specific tests everyone should request from their doctor.
Jump to:
Inflammation: The Silent Threat Cholesterol Alone Can’t Predict
Most people—and even many physicians—underestimate the role of inflammation in cardiovascular disease. Recent research makes one thing clear: perfectly controlled cholesterol doesn’t eliminate heart attack risk if inflammation remains unchecked.
The landmark CANTOS trial enrolled over 10,000 patients with existing heart disease. Their LDL cholesterol was already well-managed, with a median of just 82 mg/dL. Yet their inflammation levels remained elevated, measured by a test called high-sensitivity CRP.
Researchers asked a simple question: what happens if inflammation drops without touching cholesterol at all?
One group received a drug targeting inflammation with zero effect on cholesterol. The results were striking. Major cardiovascular events dropped by 15%. Patients whose high-sensitivity CRP fell below 2 saw even greater benefits—a 25% reduction in major events and a 31% reduction in death from any cause.
A larger analysis of over 31,000 statin users reinforced these findings. Even with treated LDL, those with high-sensitivity CRP above 2 had double the risk of cardiovascular death compared to those with low inflammation.
Cholesterol and inflammation are separate problems, and you have to address both.
In fact, the American College of Cardiology issued a scientific statement confirming that high-sensitivity CRP predicts cardiovascular risk as well as—or better than—standard cholesterol numbers.
Dr. Kim always checks and trends high-sensitivity CRP with his patients. When elevated, he investigates root causes: excess visceral fat, insulin resistance, poor sleep, chronic stress, or untreated dental issues. Most are fixable—and when addressed, inflammation drops and risk plummets.
Why Standard LDL Tests Miss Critical Risk
Most routine panels measure LDL-C, which offers a decent snapshot but doesn’t reveal the full picture. That’s why someone with “normal” LDL can still face elevated heart disease risk.
Dr. Kim recommends checking ApoB (Apolipoprotein B) for a more accurate assessment.
LDL is just one type of lipoprotein transporting cholesterol. Others—like VLDL (very low-density lipoprotein) and IDL (intermediate-density lipoprotein)—also contribute to plaque buildup. Normal LDL doesn’t rule out risk from these other particles.
ApoB measures all atherogenic particles. Each cholesterol-carrying particle—LDL, IDL, VLDL—has one ApoB molecule attached. Measuring ApoB counts every dangerous particle, capturing total risk.
Usually, ApoB and LDL move together. High LDL typically means high ApoB, and vice versa. But discrepancies emerge with insulin resistance, which includes prediabetes, type 2 diabetes, fatty liver, PCOS, and high blood pressure.
Insulin resistance affects an estimated 40% of U.S. adults without diabetes. For these individuals, tracking ApoB becomes essential.
The Dangerous Flaw in 10-Year Risk Calculators
Most physicians focus on short-term risk using the ASCVD risk calculator, which estimates heart attack or stroke probability over the next decade. Low risk? Come back next year.
But atherosclerosis doesn’t develop in 10 years. Plaque formation begins as early as adolescence, visible even in teenagers. It accumulates silently for decades before triggering a heart attack—typically in someone’s 60s or 70s.
By the time a 10-year risk calculator sounds an alarm, plaque has been forming for 30 to 40 years. Reversal becomes far more difficult.
I think of it like driving full speed toward a cliff and only hitting the brakes when you’re right at the edge.
Dr. Kim takes a different approach. Instead of the next 10 years, he thinks 30 to 40 years ahead. His goal: lower ApoB below the 5th percentile of the population—roughly below 60 mg/dL.
Without ApoB data, he recommends LDL below 60 or 70 mg/dL, thresholds where studies show plaque development begins slowing or stopping.
Lipoprotein(a): The Genetic Time Bomb
About one in five people carry a genetic marker that can double or triple heart attack risk—and it doesn’t appear on standard cholesterol panels.
That marker is Lipoprotein(a), or Lp(a). Elevated Lp(a) is likely one of the most common reasons healthy people in their 40s suffer heart attacks or strokes without warning.
Lp(a) is almost entirely genetic. Diet and exercise can’t meaningfully lower it. Most people remain unaware until something serious happens.
Structurally similar to LDL, Lp(a) carries an extra protein that makes it far more dangerous. This structure accelerates plaque formation and increases rupture risk, raising clot likelihood. Lp(a) also drives calcium buildup on the aortic valve, potentially leading to aortic stenosis—a condition causing valve stiffness, narrowing, and eventual heart failure.
The American Heart Association now recommends all adults check Lp(a) at least once. Because it’s genetic and stable throughout life, one test suffices—but knowing your number is critical.
No FDA-approved medications exist yet, but several therapies are in phase three trials with promising data. Effective treatments appear imminent.
Meanwhile, strategy focuses on aggressively lowering overall cardiovascular risk:
- Minimize ApoB as much as possible
- Control blood pressure tightly
- Address insulin resistance comprehensively
- Reduce inflammation through lifestyle interventions
Insulin Resistance: The Root Cause Hiding in Plain Sight
Insulin resistance may be the most common root cause driving both inflammation and cholesterol problems in people who otherwise appear healthy.
Insulin resistance occurs when the body struggles handling blood sugar. It manifests as fatty liver, high blood pressure, prediabetes, type 2 diabetes, PCOS, and high triglycerides.
It may actually drive heart disease more powerfully than cholesterol.
In the Quebec Cardiovascular Study, people with high insulin levels—characteristic of insulin resistance—had more than five times the risk of heart disease. This risk exceeded that from high LDL or ApoB.
Even men with normal cholesterol but high insulin faced elevated heart problem risk.
This makes insulin resistance easy to miss. Fasting blood sugar and A1C can look completely normal while significant insulin resistance exists. Doctors reviewing those numbers might declare everything fine.
What those tests don’t reveal: how much harder your pancreas works to maintain normal ranges. If blood sugar stays normal only because your pancreas operates at triple capacity, that’s not health—it’s compensation. And compensation exacts a toll.
To catch insulin resistance early, request a fasting insulin level alongside fasting glucose and A1C. High insulin with normal glucose signals pancreatic overwork.
The good news? Insulin resistance is reversible, especially when detected early. Fixing it improves nearly every cardiovascular risk simultaneously: ApoB drops, triglycerides normalize, blood pressure falls, inflammation resolves.
Key interventions include:
- Reducing visceral fat
- Regular aerobic and resistance training
- Cutting refined carbohydrates and ultraprocessed foods
For many patients, these steps produce dramatic improvements within months.
Beyond Blood Tests: Why Imaging Matters
ApoB, Lp(a), fasting insulin, and high-sensitivity CRP are blood markers revealing how favorable or unfavorable biology is for plaque formation.
But they don’t show whether plaque has already started building. For that, imaging becomes essential.
Tools include:
- Coronary artery calcium (CAC) scoring
- Coronary CT angiography
- Carotid intima-media thickness (CIMT) ultrasound
Each test provides unique information useful in different clinical situations. Dr. Kim is preparing a dedicated video exploring exactly which imaging tests to request and how to interpret them.
The takeaway is clear: standard checkups leave dangerous gaps. Requesting the right tests—high-sensitivity CRP, ApoB, Lp(a), fasting insulin, and appropriate imaging—can reveal hidden risks decades before symptoms emerge, when intervention still changes outcomes dramatically.
